Nirsevimab-resistant respiratory syncytial virus variants remain rare, but continued molecular surveillance is crucial. Read ...
A single dose of the recombinant respiratory syncytial virus (RSV) vaccine demonstrates effectiveness against infections and associated hospitalizations in veterans aged 60 years or older during ...
Respiratory syncytial virus (RSV) infections resurged earlier after the COVID-19 pandemic than before, with more severe cases requiring increased respiratory support, a study showed. This analysis ...
The inventors have created a reverse genetics system for RSV strain B1 of antigenic subgroup B encoding a replication-competent recombinant RSV that contains a codon-optimized G ORF and expresses ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback